- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 88,530 | 18.06.24 17:35:47 | +0,840 | +0,96% | 88,140 | 88,190 | 87,800 | 88,530 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 964,400 | 19.06.24 08:18:23 | -5,200 | -0,54% | 964,000 | 970,000 | 964,400 | 969,600 |
